| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 602.1 | 556.5 | 579.5 |
| Other income | 15.5 | 8.4 | 9.6 |
| Total income | 617.7 | 564.8 | 589.1 |
| Profit before exceptional items & tax | 138.9 | 142.5 | 118.8 |
| Exceptional items | 0.3 | -8.3 | 0.0 |
| Profit before tax | 139.2 | 134.2 | 118.8 |
| Net profit | 104.2 | 100.4 | 88.3 |
| Operating margin | 22.5% | 23.8% | 20.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +18.00% |
|---|---|
| Net profit, quarter on quarter | +3.80% |
| Revenue, year on year | +3.90% |
BSE results filing, NSE: SAILIFE. Figures extracted from the filing.
Sai Life Science Ltd: key numbers
- Share price
- ₹1,558.10
- Market cap
- ₹33,097 Cr
- Revenue (annual)
- ₹2,192 Cr
- Net profit (annual)
- ₹348.9 Cr
- P/E (TTM)
- 91.5×Sector 47.4×
- Promoter holding
- 34.53%-0.08% QoQ
- FII holding
- 19.65%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sai Life Science Ltd
All →Sai Life Science Employee Stock Options
Sai Life Sciences Limited has announced the allotment of equity shares under its ESOP scheme. This allotment increases the company's paid-up share capital.
Sai Life Science Employee Stock Options
Sai Life Sciences allotted 24,000 shares upon exercise of ESOP 2008 options at ₹188.90 per share. This issuance increases the company's paid-up equity share capital.
- Value
- ₹0.45 Cr
Sai Life Science Annual General Meeting
Sai Life Sciences summarised proceedings of its 27th AGM held 17 Sep 2026. Shareholders adopted FY25-26 financials and re-appointed MD Krishnamraju Kanumuri.
Sai Life Science Employee Stock Options
Sai Life Sciences Limited allotted 80,600 equity shares under its ESOP/ESPS scheme. This increased the company's total paid-up share capital to ₹21.24 Crore.
Sai Life Science Employee Stock Options
Sai Life Sciences Limited allotted 80,600 equity shares following the exercise of options under its 2008 and 2018 ESOP plans. The total paid-up capital increased to ₹21.24 Crore.
- Value
- ₹0.43 Cr
Sai Life Science Other Announcement
Sai Life Sciences submitted its Business Responsibility and Sustainability Report (BRSR) and ESG Databook for the financial year 2025-26, as required by regulatory norms.